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A Genomewide Search Finds Major Susceptibility Loci
for Nicotine Dependence on Chromosome 10 in African
Americans
Ming D. Li, Thomas J. Payne, Jennie Z. Ma, Xiang-Yang Lou, Dong Zhang, Randolph T. Dupont,
Karen M. Crews, Grant Somes, Nancy J. Williams, and Robert C. Elston
Epidemiological studies have demonstrated that genetic factors account for at least 50% of the liability for nicotine
dependence (ND). Although several linkage studies have been conducted, all samples to date were primarily of European
origin. In this study, we conducted a genomewide scan of 1,261 individuals, representing 402 nuclear families, of African
American (AA) origin.We examined 385 autosomalmicrosatellitemarkers forND,whichwas assessed by smokingquantity
(SQ), the Heaviness of Smoking Index (HSI), and the Fagerstro¨m Test for ND (FTND). After performing linkage analyses
using various methods implemented in the GENEHUNTER and S.A.G.E. programs, we found a region near marker
D10S1432 on chromosome 10q22 that showed a signiﬁcant linkage to indexed SQ, with a maximum LOD score of 4.17
at 92 cM and suggestive linkage to HSI, SQ, and log-transformed SQ. Additionally, we identiﬁed three regions that met
the criteria for suggestive linkage to at least one ND measure: on chromosomes 9q31 at marker D9S1825, 11p11 between
markers D11S1993 and D11S1344, and 13q13 between markers D13S325 and D13S788. Other locations on chromosomes
15p11, 17q25, and 18q12 exhibited some evidence of linkage for ND (LOD 11.44). The four regions with signiﬁcant or
suggestive linkage were positive for multiple ND measures by multiple statistical methods. Some of these regions have
been linked to smoking behavior at nominally signiﬁcant levels in other studies, which provides independent replication
of the regions for ND in different cohorts. In summary, we found signiﬁcant linkage on chromosome 10q22 and suggestive
linkage on chromosomes 9, 11, and 13 for major genetic determinants of ND in an AA sample. Further analysis of these
positive regions by ﬁne mapping and/or association analysis is thus warranted. To our knowledge, this study represents
the ﬁrst genomewide linkage scan of ND in an AA sample.
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Tobacco smoking is a major world health problem, and
nearly one-third of the global adult population smokes to-
bacco products.1 Nicotine dependence (ND [MIM188890]),
likemany other substance-dependence disorders, is a com-
plex trait determined strongly by both genetic and envi-
ronmental factors.2,3 Our recent meta-analysis of reported
twin studies indicated that genetic factors account for at
least 50% of the liability for this complex trait.3 Thus,
identifying the genes that predispose one to ND and un-
derstanding its molecular mechanisms is vital to preven-
tion and treatment.
At least 10 studies have mapped susceptibility loci for
ND through use of genomewide linkage analysis of smok-
ing behavior.4–13 Although numerous regions have been
identiﬁed as susceptibility loci for ND,most have not been
replicated, except for those on chromosomes 9q22 and
11p11, which have received broad support.5,14 Further-
more, almost all participants in those studies were pri-
marily of European origin. Because there are known dif-
ferences in smoking patterns and in ND risk across ethnic
groups, which may reﬂect different risk loci,15–18 it is im-
portant to conduct linkage analysis across populations.
The primary purpose of the present study was to identify
susceptibility loci for ND in an African American (AA)
sample.
Participants were of AA origin from the Mid-South To-
bacco Family (MSTF) cohort, recruited primarily from the
states of Tennessee, Mississippi, and Arkansas during 1999–
2004. Proband smokers were required to be at least 21
years old, to have smoked for at least the past 5 years, and
to have consumed an average of 20 cigarettes per day for
the past 12 mo. Smoking participants were assessed for
ND with the Fagerstro¨m Test for Nicotine Dependence.19
Once a proband and a full sibling who was also nicotine
dependent (for most of our families) were identiﬁed, ad-
ditional siblings and biological parents were recruited
whenever possible, regardless of their smoking status. In
the case where biological parents of a proband were not
available, we attempted to recruit at least three of the pro-
band’s full siblings. A total of 1,261 subjects from 402 AA
families were included in the study. Given the recruitment
criteria employed in the study, nonsmokers could not be
considered nicotine naive and were included in the link-
age analyses. The family size had a range of 2–9, and the
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Table 1. Demographic and Pedigree Characteristics of
the Data Set
Characteristic Value
No. of families 402
Mean SD no. of family members (range) (2–9)3.14 0.78
No. of genotyped subjects 1,261
Mean SD age (in years) 40.07 14.56
Percentage female 66.1
No. of smokers 1,013
Mean SD age at smoking onset (in years) 17.36 4.79
Mean SD no. of smoking years 21.06 12.52
No. SD of cigarettes per d 22.16 11.82
Mean SD HSI score 3.74 1.49
Mean SD FTND score 6.27 2.17
No. of study families with:
0 Parent included in the study 187
1 Parent included in the study 199
2 Parents included in the study 16
No. of study families with:
1 Smoker 31
2 Smokers 210
3 Smokers 161
No. of study families with:
1 Full sibling 22
2 Full siblings 174
3 Full siblings 206
No. of study pairs of:
Parent and offspring 512
Sib pairs 926
Sisters 405
Brothers 180
Brother and sister 341
Figure 1. Multipoint linkage–analysis results from the EM-HE regression method of GENEHUNTER (A) and the SIBPAL program of S.A.G.E.
(B) for indexed SQ, SQ, HSI, and log-transformed SQ on chromosome 10. Genetic distance (in cM) is plotted on the X-axis against the
LOD score from GENEHUNTER (A) and against log10(P) from SIBPAL (B). The horizontal line in each graph corresponds to the threshold
for suggestive linkage.28,38
average size (SD) was . Of these families,3.14 0.78
53.5% had at least one biological parent recruited, 43.3%
had two full siblings, and 51.2% had three or more full
siblings. Among the participants of the study, themajority
(smokers 69.4%; nonsmokers 65.7%) had a high school
education or less, and most of them were from families
considered low income. Descriptive statistics regardingde-
mographic and clinical characteristics of the sample are
presented in table 1. All participants provided informed
consent, and the study was approved by all involved in-
stitutional review boards.
Several measures were used to assess ND, including the
number of cigarettes smoked per day,20,21 current tobacco
use,22 and Fagerstro¨m Test for ND (FTND) score.23,24 Al-
though these measures are not identical, they are highly
correlated.2,3 In the present study, the ND of each smoker
was ascertained by the three measures most commonly
used in the literature: smoking quantity (SQ), deﬁned as
the number of cigarettes smoked per day; the Heaviness
of Smoking Index (HSI), a 0–6 scale, which includes SQ
and smoking urgency (i.e., how soon after waking the
subject smokes the ﬁrst cigarette; these are questions 1
and 3 of the FTND); and the FTND score, a 0–10 scale.19
The correlation coefﬁcients among the three NDmeasures
had a range of 0.88–0.94 in our sample. After considering
the effect of abnormal distribution of the phenotype on
our linkage results, as we did previously,11 we transformed
nonzero SQ value to a natural log-scale or an indexed SQ,
inwhich individuals who smoked 1–10, 11–20, 21–30, and
31 cigarettes per d were assigned the values 0, 1, 2, and
3, respectively, per the FTND item coding. Skewness and
kurtosis values, respectively, were 1.20 and 2.69 for the
SQ,0.80 and 1.19 for log-transformed SQ, 0.41 and0.75
for indexed SQ, 0.46 and 0.15 for HSI, and 0.55 and
0.40 for the FTND.
DNA was extracted from peripheral-blood samples of
each participant. Genotyping for microsatellite markers
was performed at the Center for Inherited Disease Re-
search (CIDR) at Johns Hopkins University. The CIDR
marker set was composed primarily of trinucleotide and
tetranucleotide repeats and consisted of 404 markers (385
on autosomal chromosomes, 16 on chromosome X, and
3 on chromosome Y), with average spacing of 8.6 cM
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Figure 2. Linkage-analysis results of various ND measures on chromosomes 9, 11, and 13. Genetic distance (in cM) is plotted on the
X-axis against log10(P) from SIBPAL for panels A and C and against the LOD score from GENEHUNTER for panel B. The horizontal line
in each graph corresponds to the threshold for suggestive linkage.28,38
Table 2. Chromosomal Regions Potentially Linked to Different ND Measures
Chromosome, Marker(s)
(Distance, in cM, from p-ter),
and ND Measure
Marker at
or Near
Peak
Peak
Position
(cM)
Chromosome
Location Nominal P
Maximum
LOD
Score
Program Used for
Linkage Analysis
Chromosome 15:
D15S128-D15S165 (0–20):
FTND D15S128 6 15p11.1 32.2# 10 SIBPAL
HSI D15S128 6 15p11.1 38.6# 10 SIBPAL
Indexed SQ D15S128 6 15p11.1 21.7# 10 SIBPAL
Chromosome 17:
D17S2193-D17S928 (89–126):
Indexed SQ D17S784 117 17q25.3 1.99 Nonparametric (GENEHUNTER)
SQ D17S784 117 17q25.3 1.68 Nonparametric
HSI D17S784 117 17q25.3 1.34 Nonparametric
Chromosome 18:
D18S843-D18S1364 (28–100):
FTND D18S535 67 18q12.1-18q12.2 32.0# 10 SIBPAL
HSI D18S535 69 18q12.1-18q12.2 37.5# 10 SIBPAL
Indexed SQ D18S535 69 18q12.1-18q12.2 21.2# 10 SIBPAL
throughout the genome. There were no gaps in the map
that were 118 cM, and the average marker heterozygosity
was 0.76. Only 385 autosomal markers were used in the
present study. Extensive quality checks were performed to
verify the consistency of marker genotyping and of stated
pedigree relationships. The PedCheck program was used
to identify any inconsistent Mendelian inheritance, non-
paternity, or typing errors.25 The errors (a total of 7,971
Mendelian inconsistencies, an ∼1.1% error rate) identiﬁed
in PedCheck were assumed to have occurred in the ge-
notyping process, and the associated markers were set to
“missing” for the corresponding members. Also, we used
all markers to check pedigree errors by means of the
RelCheck program.26 To avoid bias, the individuals with a
false genetic (blood) relationship were excluded from fur-
ther linkage analysis.
Two linkage analysis programs (SIBPAL in S.A.G.E. v.
5.1 and GENEHUNTER v. 2.1) were used. For the GENE-
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Figure 3. Multipoint linkage–analysis results from the SIBPAL
program of S.A.G.E. The legend is available in its entirety in the
online edition of The American Journal of Human Genetics.
Figure 4. Multipoint linkage–analysis results from the nonpara-
metric method of GENEHUNTER. The legend is available in its en-
tirety in the online edition of The American Journal of Human
Genetics.
HUNTER program, we used the expectation-maximization
(EM)–Haseman-Elston (HE) regression and nonparametric
method to analyze all ND measures. Multipoint methods
were used for estimating identity-by-descent (IBD) sharing
needed for calculating these statistics. Other conditions
for running the programs used the relevant program de-
faults. For S.A.G.E., we used genotypes from all family
members to calculate multipoint IBD allele-sharing dis-
tributions with the GENIBD program. SIBPAL, a model-
free S.A.G.E. linkage program, was then used to perform
the linkage analysis on the basis of all possible sib pairs.
Evidence of linkage was assessed by an HE regression, with
dependent-variable options W3 and W4, both of which
transform the sib pair’s trait values to weighted combi-
nations of the squared trait difference and squared mean
corrected trait sum, but the former option adjusted for the
nonindependence of sib pairs, whereas the latter option
adjusted for the nonindependence of sib pairs and the
nonindependence of squared trait sums and differences.27
Otherwise, default options were used for all parameters in
the trait regression method. Sex and age were included as
covariates for all analyses reported in this communication.
To determine empirical estimates of genomewide signiﬁ-
cance level, we performed linkage analysis on 1,000 rep-
licate permutations, using the approach we described else-
where,12 with both the family structure and the IBD struc-
ture kept intact. The empirical signiﬁcance level of an ob-
served LOD score or P value for an ND measure of interest
was then estimated by counting the proportion of genome
scans containing one or more peaks of that value. The
signiﬁcant linkage threshold was deﬁned as the LOD score
or P value occurring in 50 of the 1,000 permutations, cor-
responding to a probability of 0.05 in a genome scan.28
The S-Plus 6.1 and SAS 8.2 packages were used to prepare
the required data format for the linkage-analysis programs
and to summarize the data generated from the programs.
Multipoint linkage analyses revealed signiﬁcant or sug-
gestive evidence of linkage on four chromosomes (ﬁgs.
1 and 2), on the basis of the genomewide signiﬁcance
threshold of Lander and Kruglyak.28 As shown in ﬁgure
1, a single region on chromosome 10q22 showed signiﬁ-
cant evidence of linkage to indexed SQ between markers
D10S1208 and D10S2470. This linkage was detected by
both the EM-HE method of GENEHUNTER, with a LOD
score of 4.17 at 92 cM (the empirical threshold LOD
score at the genomewide .05 signiﬁcance level for indexed
SQ is 3.50), and SIBPAL, with multipoint nominal Pp
at 94 cM (W3 and W4 options yielded essentially.000060
the same results on the ND measures: close to the empir-
ical P value of , with an a level of .05). The55.98# 10
evidence of linkage of the region on chromosome 10q22
to ND was further supported by the linkage results from
analysis of three other ND measures—namely, SQ, log-
transformed SQ, and HSI—with use of both linkage pro-
grams (ﬁg. 1A and 1B).
We found three additional regions, located on chromo-
somes 9, 11, and 13, that showed suggestive linkage to at
least one of the ND measures (ﬁg. 2A–2C). For example,
we found suggestive evidence of linkage to indexed SQ
and FTND near marker D11S1344 on chromosome 11p11,
with LOD scores of 2.35 and 2.31, respectively (ﬁg. 2B). In
the same region, betweenmarkersD11S1392 andD11S1344
(∼43–58 cM), we found evidence of potential linkage to
HSI, with a LOD score of 2.15 at 51 cM. On chromosome
9q31 at marker D9S1825, we found suggestive linkage to
FTND with a multipoint nominal P value of .00083 and
potential linkage to HSI ( ) at a distance of 136Pp .0021
cM from the p telomere (ﬁg. 2A). Additionally, we found
suggestive linkage of SQ to chromosome 13q13 between
markers D13S325 and D13S788, with multipoint nominal
at 42 cM (ﬁg. 2C).Pp .000135
Three other regions showed a multipoint nominal P val-
ue or LOD score that was just below the threshold for sug-
gestive linkage. These include the region on chromosomes
15p11 at marker D15S128, 17q25 at marker D17S784, and
18q12 between markers D18S535 and D18S851 (table 2).
Of these potential linkages, we found that FTND showed
a peak on chromosome 15 at 6 cM and a peak on chromo-
some 18 at 67 cM, with multipoint nominal P values of
.0022 and .002, respectively. Similarly, we found evidence
of a potential linkage of indexed SQ to chromosome 17
at 117 cM, with a LOD score of 1.99. Such a potential
linkage to these three regions has been supported by the
other ND measures used in this study (see table 2 for
details).
The strong statistical support for linkage of ND at
10q22.1-10q22.2 is novel and highly signiﬁcant. In a pre-
vious genome scan, a weak linkage signal for ND (assessed
by the FTND) was observed for a region that overlapped
slightly with the region identiﬁed herein, with a P value
of .0004 at 127.1 cM near marker D10S2469, in the Christ-
church, New Zealand,29 sample. Given the fact that the
subjects of that study were primarily of European origin,
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Figure 5. Multipoint linkage–analysis results from EM-HE re-
gression method of GENEHUNTER. The legend is available in its
entirety in the online edition of The American Journal of Human
Genetics.
whereas those in the present study were of AA origin, this
region appears to be a potential susceptibility locus forND
in both ethnic groups, with likely smaller effects for Eu-
ropean compared with AA smokers. On the basis of the
human genome sequence from public databases (Map
Viewer), there are ∼400 genes within this region. Of these,
the genes ionotropic glutamate receptor delta 1 (GRID1),
dynamin binding protein, and catechol-O-methyltrans-
ferase domain containing 1 represent plausible candidates
for an association study, on the basis of their biological
function(s) and the biochemical pathways involved in
drug addiction.30–32 However, there is no reported study
demonstrating an association of these candidate genes
with ND or with other psychiatric disorders, with the ex-
ception that GRID1 has been associated with bipolar dis-
order and schizophrenia.32
Of the linked regions identiﬁed in this study, the sus-
ceptibility loci on chromosomes 9 and 11 have been re-
ported in multiple studies. Elsewhere, we identiﬁed an
∼13-cM interval on chromosome 9q22 that showed sug-
gestive linkage to ND in Framingham Heart Study (FHS)
families.11 Linkage of this region to smoking behavior at
a nominally signiﬁcant level has been supported by three
other independent studies.7,9,10 Several positional candi-
date genes, such as GABAB receptor subunit 2 (GABAB2
[MIM 607340]) and neurotrophic tyrosine kinase receptor
type 2 (NTRK2 [MIM 600456]), within the 9q22 linkage
region were found to be associated with ND in our recent
family-based association study of the MSTF sample.33,34
The region on chromosome 11q12 is another susceptibil-
ity locus for ND that has been reported in multiple stud-
ies.4,9,11,35 Of these studies, we have reported the strongest
linkage results for smoking consumption on chromosome
11q12, with a LOD score of 3.95 in the FHS sample.11 This
linkage has been replicated at a nominal level by Goode
et al.,35 with a LOD score of 1.10 for cigarette consumption
in the same cohort. Recently, Morley et al.4 reported a
suggestive linkage of cigarette consumption to chromo-
some 11q13 ( ) in an Australian twin sample.Pp .0000568
In another study, likely linkage on chromosome 11q14 for
smoking behavior was reported, with a LOD score of 1.64.9
Our ﬁnding of suggestive linkage to ND on chromosome
11 is further supported by a signiﬁcant association with
brain-derived neurotropic factor (BDNF [MIM 113505]),
located within the region at 11p14.1 near the linkage peak
shown in ﬁgure 2B.36
Another region showing suggestive linkage to ND is lo-
cated on chromosome 13q12, with a multipoint nominal
P value of . Previously, this region was weakly41.35# 10
linked to smoking behavior in two independent studies,
with a LOD score of 1.3 for both.13,37 However, because
we detected suggestive linkage of the region on chromo-
some 13 to SQ only, more replication studies are needed
to determine whether this linkage was attributable to
chance or is derived from loci with small effects. Further,
we identiﬁed potential linkage of chromosomes 15, 17,
and 18 to ND. Although these three regions do not meet
the threshold for suggestive linkage to ND,28 they poten-
tially harbor susceptibility genes for ND, since all these
regions have been linked to smoking behavior at a nom-
inally signiﬁcant level in independent samples. For ex-
ample, Bierut et al.9 identiﬁed a linkage of habitual smok-
ing to chromosome 15 at 14 cM, with a LOD score of 1.25,
in the sample from the Collaborative Study on the Ge-
netics of Alcoholism (COGA). Using the same COGA data
set, Bergen et al.7 reported potential linkage to chromo-
some 17 at ∼111 cM for ever-smoking versus never-smok-
ing status and to chromosome 18 at 18.7 cM for number
of cigarette packs per year, with P values of .0001 and
.0002, respectively.
In conclusion, we provide strong evidence of signiﬁcant
linkage of ND to chromosome 10 and suggestive linkages
to chromosomes 9, 11, and 13 in an AA sample. Further,
we identiﬁed three regions on chromosomes 15, 17, and
18 that showed potential linkage to ND. There is some
overlap between our results and those of previous genome
scans that examined smoking behavior in other ethnic
samples. To our knowledge, our study represents the ﬁrst
genomewide scan for ND in an AA population. Given the
potential ethnic differences in smoking patterns and nic-
otine metabolism, this study may shed light on strategies
for searching for susceptibility loci/genes for ND, espe-
cially in AA smokers. These regions represent excellent
candidate loci that harbor allelic variants that alter vul-
nerability to ND. Further analysis of these regions by ﬁne
mapping or association analysis is thus warranted.
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